Thrombocytopenia is a common complication in patients with chronic liver disease, and up to 78% of patients with cirrhosis are accompanied by varying degrees of thrombocytopenia. When patients with chronic liver disease have thrombocytopenia, the risk of operation-related bleeding is significantly increased, resulting in a series of clinically invasive tests and treatments that cannot be performed as usual. Therefore, when surgery or other invasive tests are required, the need for a rapid increase in platelet count in a short period of time is particularly urgent in patients with CDD-associated thrombocytopenia.